ECM
INSM icon

Everence Capital Management’s Insmed INSM Stock Holding History

Everence Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Sell
3,560
-2,824
-44% -$342K 0.02% 535
2026
Q1 		$1.04M Sell
6,384
-390
-6% -$60K 0.06% 235
2025
Q4 		$1.18M Buy
6,774
+331
+5% +$60.4K 0.07% 216
2025
Q3 		$928K Buy
6,443
+1,343
+26% +$165K 0.06% 253
2025
Q2 		$513K Hold
5,100
– – 0.03% 373
2025
Q1 		$389K Hold
5,100
– – 0.03% 446
2024
Q4 		$352K Buy
+5,100
New +$367K 0.02% 501

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Everence Capital Management's INSM Position: Q2 2026 in Review

Everence Capital Management reduced its Insmed (INSM) stake by 44% in Q2 2026, selling an estimated $342K and leaving 3,560 shares worth $380K. The position accounts for 0.02% of the portfolio, ranked #535.

Everence Capital Management first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.18M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Everence Capital Management held 3,560 shares of Insmed worth $380K as of Q2 2026.
  • Everence Capital Management sold 2,824 Insmed shares in Q2 2026, an estimated $342K.
  • Insmed made up 0.02% of Everence Capital Management's portfolio in Q2 2026, its #535 holding.
  • Everence Capital Management first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • Everence Capital Management's Insmed position peaked at $1.18M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.